Amgen India appoints Naveen Gullapalli to lead Hyderabad tech center as new MD

Biotechnology firm Amgen has appointed Naveen Gullapalli as the managing director for its India operations. Gullapalli will now lead the Amgen India Technology and Innovation site in Hyderabad. In this role, he will leverage his experience in leading global operations and adjoining functions across the pharmaceutical, finance and technology industries.

Amgen’s Hyderabad site was announced in August 2024. It is a critical component of the company’s global strategy for accelerating digital transformation and innovation efforts. This center is focused on building and scaling advanced technology solutions and digital capabilities, supporting key areas such as AI data science, and life sciences. 

 "Amgen India is key to furthering our global vision of unlocking the convergence of biotech and tech to accelerate innovation and help meet the needs of a globally aging population. Naveen’s wealth of experience and strategic leadership will drive the success of this new site,” said Som Chattopadhyay, national executive for India at Amgen. 

Gullapalli joins Amgen from Novartis where he led the development of their Global Center in Hyderabad and their network of six centers across the world. His deep experience in developing specialized skills and enabling business transformation aligns closely with Amgen’s vision for its Hyderabad site as a global technology and innovation hub, Amgen said in a statement.

“India’s talent pool offers a compelling opportunity for Amgen to deliver world-class functional excellence, operational excellence, innovation and technology-led transformation,” said Naveen Gullapalli. “I am excited for this opportunity to advance tech from India in order to serve more patients globally.” he added.